
Home » New Partnership Between GSK and the Gates Foundation to Speed Research Into Vaccines
New Partnership Between GSK and the Gates Foundation to Speed Research Into Vaccines
November 4, 2013
GlaxoSmithKline and the Bill & Melinda Gates Foundation have put $1.8 million into a new joint venture that will attempt to make vaccines more resistant to heat.
World Pharma News
World Pharma News
Upcoming Events
-
21Apr
-
26Apr
-
06May
-
12May
-
25May